top of page

Checking in with HSBC Innovation Banking's Ryan Roller on the state of biotech, and the financing environment for both investment firms and companies

  • 7 hours ago
  • 1 min read

He discusses opportunities and areas of caution, such as recent turbulence at FDA, and how they have been affecting companies. Plus, the environment for VC and PE firms to raise new funds, and what it means for public and private companies.





Note: HSBC Innovation Banking is a sponsor of BiotechTV

 
 

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page